Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia
1998

Prognostic Factors in Acute Myeloid Leukaemia

Sample size: 76 publication Evidence: moderate

Author Information

Author(s): N Wakimoto, A Yokoyama, J Okabe-Kado, N Nagata, K Motoyoshi, Y Honma

Primary Institution: Saitama Cancer Center Research Institute

Hypothesis

The study investigates the correlation between nm23 gene expression levels and patient survival in acute myeloid leukaemia (AML).

Conclusion

Low expression levels of both nm23-H1 and -H2 are associated with better prognosis in AML patients.

Supporting Evidence

  • nm23-H1 and -H2 were overexpressed in AML compared to normal blood cells.
  • Patients with low nm23-H1 expression had significantly better survival rates.
  • Statistical analysis showed a significant correlation between nm23-H1 and -H2 expression levels.

Takeaway

This study found that patients with lower levels of certain proteins (nm23-H1 and -H2) have a better chance of surviving acute myeloid leukaemia.

Methodology

The study analyzed nm23-H1 and -H2 mRNA levels in 76 AML samples using reverse transcriptase-polymerase chain reaction.

Limitations

The study's findings may not be generalizable due to the specific patient population and the limited number of cases for some subtypes.

Participant Demographics

The study included 76 patients with newly diagnosed acute myelogenous leukaemia, with a mean age of 50 years.

Statistical Information

P-Value

p<0.0005

Statistical Significance

p<0.0005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication